Jennifer Shehan, MD
Otolaryngology · Boston, MANPI 1598269359
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Synthes GmbH at 50.7% of the total. Reporting peaked in 2024 at $1,483 and has fallen 89.3% since, to $159 in 2025.
Across 13 payments — averaging $164.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$1K
- AbbVie$260
- Stryker$185
- Intersect ENT, Inc.$133
- Inspire Medical Systems, Inc.$125
- Integra Lifesciences Corporation$117
- plus $236 from 4 others
What the payments were for
- Speaking & faculty fees$25012%
- Travel & lodging$83639%
- Food & beverage$1,05649%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 2 | $1,086 |
| AbbVie | 2 | $260 |
| Stryker | 2 | $185 |
| Intersect ENT, Inc. | 1 | $133 |
| Inspire Medical Systems, Inc. | 1 | $125 |
| Integra Lifesciences Corporation | 1 | $117 |
| Medtronic | 1 | $98 |
| Johnson & Johnson | 1 | $91 |
| Neurent Medical Limited | 1 | $27 |
| Merz North America, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$352
- SMARTLOCK$263
- PROPEL$133
- VSP SYSTEM, VSP CRANIAL$131
- Inspire$125
- INTEGRA DERMAL REGENERATION TEMPLATE$117
- PRIMATRIX$117
How this compares
$2,143 in reported general payments places this provider in the 70th percentile of 298 otolaryngology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 17 | $331 |
| Ipratropium Bromide | 11 | $203 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Boston
- Dennis PoeBoston$264K
- Peter WeberBoston$157K
- Kevin EmerickBoston$89K
- Benjamin BleierBoston$77K
- Gregory RandolphBoston$56K
- Daniel LeeBoston$52K
- Marika RussellBoston$50K
- Isaac WassermanBoston$50K
- Phillip HuyettBoston$48K
- Thomas CarrollBoston$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.